1e
19
1
49
2
2
18
1b
1d
18
36
6c
1d
2 29
1d
25
Jeremy James Flood, M.D.
88
6c
Professor of Clinical Medicine (Endocrinology, Diabetes and Metabolism)
28
6c
3
5f
Attending, Hospital of the University of Pennsylvania
62
Attending, Penn Presbyterian Medical Center
79
Chief, Division of Endocrinology, Penn Presbyterian Medical Center
98
Medical Director, Endocrinology, Diabetes, and Metabolism practice, Penn Medicine University City
11
Department: Medicine
4
1
b
1d
46
Contact information
4e
4
3
3
3
2
4
b
1f
4e
Penn Presbyterian Medical Center
25 Penn Medicine University City
3c 3737 Market St, 3rd Floor
Philadelphia, PA 19104
26
25 Penn Medicine University City
3c 3737 Market St, 3rd Floor
Philadelphia, PA 19104
35
f
13
Education:
21 9 B.S. 14 (Biology) c
3d Cornell University, Ithaca, New York, 1997.
21 9 M.D. c
7e State University of New York at Buffalo School of Medicine and Biomedical Sciences, Buffalo, New York, 2001.
c
3
3
3
3
8d
Permanent link21 9 B.S. 14 (Biology) c
3d Cornell University, Ithaca, New York, 1997.
21 9 M.D. c
7e State University of New York at Buffalo School of Medicine and Biomedical Sciences, Buffalo, New York, 2001.
c
2 29
21
1e
1d
24
2b
29
27
23
19a Passman J, Hwang J MD MS, Tang J, Epps M, Chambers C, Cook T, Fagan M, Peifer M, Flood J, Delgado K, Fraker DL, Wachtel H, Kelz RR, Herman DS. : Development of Comprehensive Decision Support to Improve Screening for Primary Hyperparathyroidism. Oral podium presentation at Nudges in Health Care Symposium in Philadelphia, PA. Sept 2024.
1c8 Hwang J, Passman J, Tang T, Fagen M, Epps M, Chambers C, Cook T, Peifer M, Flood J, Delgado K, Fraker DL, Wachtel H, Herman DS, Kelz RR.: Electronic Medical Record-Based Behavioral Nudges to Improve Screening Rates for Primary Hyperparathyroidism. Oral podium and poster presentation. Presented at American College of Surgeons Quality and Safety Conference in Denver, CO. July 2024.
17f Jesse M. Raiten, Andrea Morlok, Sarah D'Ambrosia, Michael A. Ruggero, Jeremy Flood: Perioperative Management of Patients Receiving Sodium Glucose Co-Transporter-2 Inhibitors: Development of a Clinical Guideline at a Large Academic Medical Center. Journal of Cardiothoracic and Vascular Anesthesia October 2023.
14a Passman J, Hwang J, Fagen M, Epps M, Peifer M, Flood J, Nicklin D, Delgado MK, Kelz R, Herman D: Electronic health record-based nudges to enhance screening rates for primary hyperparathyroidism: a pilot study. Nudges in Health Care Symposium September 2023.
7a Jo Kamimoto, Jorge L.; Flood, Jeremy J. : Systemic Thyroid Dysfunction 87 in Graves Disease. International Ophthalmology Clinics. Wolters Kluwer Health, Inc. 63(2): 55-63, Spring 2023.
dd L McLeer Maloney, J Flood, N Alamuddin, M Al Mukaddam: Findings from a Diabetes Support Group—A Pilot Study. Diabetes 67(Supplement 1): 720, 2018.
c6 Simon B, Flood J, Jabbour S: Type 1 Diabetes in Adults. Oxford American Endocrinology Library Oxford University Press, 2011.
100 Flood JJ, Miller JL.: Treatment of Type 2 Diabetes Mellitus with Oral Agents. A Case-based Guide to Clinical Endocrinology. Davies, Terry F. (eds.). Humana Press, Page: 359-365, 2008.
fa Ahmed I, Furlong K, Flood J, Treat VP, Goldstein BJ.: Dual PPAR alpha/gamma Agonists: Promises and Pitfalls in Type 2 Diabetes. American Journal of Therapeutics 14: 49-62, 2007.
2c
7
1d
1f
Selected Publications
135 Hvisdas CM, Goode ND, Kim DH, Silvey MJ, Flood JJ : Characterization of Interchanging Incretin Analogs in Clinical Practice: A Descriptive Report Endocrine Practice Oct 2024 Notes: Accepted for publication; published online pre-proof19a Passman J, Hwang J MD MS, Tang J, Epps M, Chambers C, Cook T, Fagan M, Peifer M, Flood J, Delgado K, Fraker DL, Wachtel H, Kelz RR, Herman DS. : Development of Comprehensive Decision Support to Improve Screening for Primary Hyperparathyroidism. Oral podium presentation at Nudges in Health Care Symposium in Philadelphia, PA. Sept 2024.
1c8 Hwang J, Passman J, Tang T, Fagen M, Epps M, Chambers C, Cook T, Peifer M, Flood J, Delgado K, Fraker DL, Wachtel H, Herman DS, Kelz RR.: Electronic Medical Record-Based Behavioral Nudges to Improve Screening Rates for Primary Hyperparathyroidism. Oral podium and poster presentation. Presented at American College of Surgeons Quality and Safety Conference in Denver, CO. July 2024.
17f Jesse M. Raiten, Andrea Morlok, Sarah D'Ambrosia, Michael A. Ruggero, Jeremy Flood: Perioperative Management of Patients Receiving Sodium Glucose Co-Transporter-2 Inhibitors: Development of a Clinical Guideline at a Large Academic Medical Center. Journal of Cardiothoracic and Vascular Anesthesia October 2023.
14a Passman J, Hwang J, Fagen M, Epps M, Peifer M, Flood J, Nicklin D, Delgado MK, Kelz R, Herman D: Electronic health record-based nudges to enhance screening rates for primary hyperparathyroidism: a pilot study. Nudges in Health Care Symposium September 2023.
7a Jo Kamimoto, Jorge L.; Flood, Jeremy J. : Systemic Thyroid Dysfunction 87 in Graves Disease. International Ophthalmology Clinics. Wolters Kluwer Health, Inc. 63(2): 55-63, Spring 2023.
dd L McLeer Maloney, J Flood, N Alamuddin, M Al Mukaddam: Findings from a Diabetes Support Group—A Pilot Study. Diabetes 67(Supplement 1): 720, 2018.
c6 Simon B, Flood J, Jabbour S: Type 1 Diabetes in Adults. Oxford American Endocrinology Library Oxford University Press, 2011.
100 Flood JJ, Miller JL.: Treatment of Type 2 Diabetes Mellitus with Oral Agents. A Case-based Guide to Clinical Endocrinology. Davies, Terry F. (eds.). Humana Press, Page: 359-365, 2008.
fa Ahmed I, Furlong K, Flood J, Treat VP, Goldstein BJ.: Dual PPAR alpha/gamma Agonists: Promises and Pitfalls in Type 2 Diabetes. American Journal of Therapeutics 14: 49-62, 2007.
2c